Gladymar’s research focussed on the allergy protective benefits of the addition of an early single dose of the whole-cell whooping cough (pertussis) vaccine into the immunisation schedule, and the reduction of the burden of food allergy and eczema in Australian children. This innovative strategy is also expected to provide a better protection against pertussis.